BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7979029)

  • 1. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases].
    Cosgarea R; Cosgarea M; Turcu T
    Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
    Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scleromyxedema associated with myopathy].
    Catalá J; López-Aldeguer J; Vílchez JJ; Chirivella M; Catalá MT
    Rev Clin Esp; 1993 Jul; 193(3):119-21. PubMed ID: 8356289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.
    Lee YH; Sahu J; O'Brien MS; D'Agati VD; Jimenez SA
    J Clin Rheumatol; 2011 Sep; 17(6):318-22. PubMed ID: 21869708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phoniatric and laryngological aspects of systemic scleroderma (author's transl)].
    Sopko J; Wey W
    HNO; 1978 Feb; 26(2):65-7. PubMed ID: 632135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Internal disease findings in Arndt-Gottron scleromyxedema].
    Lang E; Goos M
    Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the larynx in systemic lupus erythematosus and systemic scleroderma].
    Minchina RA; Fastovskiĭ IaA; Antonova NA
    Zh Ushn Nos Gorl Bolezn; 1970; 30(4):67-73. PubMed ID: 5503999
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myxedema and the voice].
    Heinemann M
    Folia Phoniatr (Basel); 1969; 21(1):55-62. PubMed ID: 5771115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arndt-Gottron scleromyxedema].
    Piper W; Hardmeier T
    Verh Dtsch Ges Inn Med; 1967; 73():394-9. PubMed ID: 5591783
    [No Abstract]   [Full Text] [Related]  

  • 14. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    Lin YC; Wang HC; Shen JL
    J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleromyxedema with myopathy and hyperthyroidism.
    Van Linthoudt D; Schumacher HR; Algeo S; Freundlich B; Schotland DL; Wood MG
    J Rheumatol; 1996 Jul; 23(7):1299-301. PubMed ID: 8823713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin.
    Shergill B; Orteu CH; McBride SR; Rustin MH
    Br J Dermatol; 2005 Sep; 153(3):650-2. PubMed ID: 16120159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arndt-Gottron scleromyxedema. Summary of 2 years treatment].
    Krajnc I
    Wien Klin Wochenschr; 1997 Dec; 109(24):960-3. PubMed ID: 9491540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin.
    Kulczycki A; Nelson M; Eisen A; Heffernan M
    Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleromyxedema.
    Wright RC; Franco RS; Denton D; Blaney DJ
    Arch Dermatol; 1976 Jan; 112(1):63-6. PubMed ID: 813582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleromyxedema with dermato-neuro syndrome.
    Gonzalez J; Palangio M; Schwartz J; Klainer AS; Bisaccia E
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):927-8. PubMed ID: 10767707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.